These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 22416677)

  • 21. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
    Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
    J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia.
    Riddell RE; Buth KJ; Sullivan JA
    Can J Anaesth; 2013 Jan; 60(1):16-23. PubMed ID: 23132043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
    Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M
    Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
    Vonk AB; Meesters MI; Schats J; Romijn JW; Jansen EK; Boer C
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):135-9. PubMed ID: 21075830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetic analysis and dosing regimen optimization of aprotinin in neonates and young infants undergoing cardiopulmonary bypass.
    Tae YM; Kwak JG; Kim BH; Jang IJ; Kim WH
    J Clin Pharmacol; 2011 Aug; 51(8):1163-76. PubMed ID: 20926755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of aprotinin on outcome after coronary-artery bypass grafting.
    Shaw AD; Stafford-Smith M; White WD; Phillips-Bute B; Swaminathan M; Milano C; Welsby IJ; Aronson S; Mathew JP; Peterson ED; Newman MF
    N Engl J Med; 2008 Feb; 358(8):784-93. PubMed ID: 18287601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery].
    Varela Crespo CA; Sanabria Carretero P; Palomero Rodríguez MA; Tormo las de Heras C; Rodríguez Pérez E; Goldman Tarlousky L
    Rev Esp Anestesiol Reanim; 2007 Mar; 54(3):155-61. PubMed ID: 17436653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative platelet dysfunction predicts blood product transfusion in children undergoing cardiac surgery.
    Zubair MM; Bailly DK; Lantz G; Sunstrom RE; Saharan S; Boshkov LK; Sochacki P; Roger Hohimer A; Lasarev MR; Langley SM
    Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):24-30. PubMed ID: 25281704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery.
    Lin CY; Shuhaiber JH; Loyola H; Liu H; Del Nido P; DiNardo JA; Pigula FA
    PLoS One; 2015; 10(5):e0126514. PubMed ID: 25954976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery.
    Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Hu S
    Ann Thorac Surg; 2010 May; 89(5):1489-95. PubMed ID: 20417766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effect of aprotinin and ε-aminocaproic acid on renal function in children undergoing cardiac surgery.
    Leyvi G; Nelson O; Yedlin A; Pasamba M; Belamarich PF; Nair S; Cohen HW
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):402-6. PubMed ID: 21419653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
    Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
    Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
    Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
    Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery.
    Graham EM; Atz AM; Gillis J; Desantis SM; Haney AL; Deardorff RL; Uber WE; Reeves ST; McGowan FX; Bradley SM; Spinale FG
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1069-76. PubMed ID: 22075061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
    Yasim A; Aşik R; Atahan E
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aprotinin reduces homologous blood transfusions when pediatric cardiac surgery must be redone].
    Ohuchi H; Okabe H; Nagata N; Kaneko Y
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):1980-5. PubMed ID: 8958711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of complications with blood transfusions in pediatric cardiac surgery patients.
    Iyengar A; Scipione CN; Sheth P; Ohye RG; Riegger L; Bove EL; Devaney EJ; Hirsch-Romano JC
    Ann Thorac Surg; 2013 Sep; 96(3):910-6. PubMed ID: 23866807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.